Tesamorelin is a synthetic Growth Hormone-Releasing Hormone (GHRH) analog widely researched for its ability to stimulate natural growth hormone release and support visceral fat reduction, body composition, recovery, and metabolic health. It is the only FDA-approved GHRH analog and is commonly studied for fat-loss and anti-aging related applications.
Tesamorelin is a synthetic 44-amino acid peptide analog of Growth Hormone-Releasing Hormone (GHRH), specifically engineered to stimulate the body’s natural production and pulsatile release of growth hormone (GH). Unlike exogenous HGH, Tesamorelin works upstream by signaling the pituitary gland to release endogenous GH while preserving the body’s natural hormonal feedback mechanisms.
Tesamorelin is recognized as the only FDA-approved GHRH analog, marketed under the brand name Egrifta for reducing excess visceral abdominal fat in HIV-associated lipodystrophy. Its unique molecular modification — the addition of a trans-3-hexenoic acid group — improves peptide stability and resistance to enzymatic breakdown, allowing more effective biological activity compared to native GHRH.
Tesamorelin binds to GHRH receptors located on somatotroph cells within the anterior pituitary gland. This stimulation promotes the release of endogenous growth hormone, which subsequently increases IGF-1 production in the liver. The resulting GH and IGF-1 signaling pathways are associated with enhanced lipolysis, metabolic regulation, recovery support, and body composition changes.
Unlike direct HGH administration, Tesamorelin maintains physiological pulsatile GH release patterns, making it distinct from continuous exogenous hormone exposure.
Tesamorelin has gained substantial interest in research involving:
Research and clinical studies have particularly highlighted Tesamorelin’s effects on reducing visceral adipose tissue (VAT), the deeper abdominal fat associated with metabolic dysfunction.
Tesamorelin is often differentiated from other GH-related peptides due to its strong clinical backing and FDA-approved status. Researchers commonly explore it for targeted visceral fat reduction while maintaining lean body mass and supporting natural GH physiology.
It is also widely discussed in advanced peptide research protocols involving metabolic optimization and performance-related body composition studies.
This product is intended strictly for laboratory and research purposes only. It is not approved for human consumption or medical use outside approved regulatory indications.
High-quality research-grade peptides and compounds engineered for scientific innovation and laboratory use.